Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Nilotinib + Paclitaxel for Advanced Cancer
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial is testing the safety of combining two drugs, nilotinib and paclitaxel, to see if they can be given safely to people with advanced cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.